Given that CRC cells with mutated PIK3CA are more dependent on glutamine, CB-839 (GLS inhibitor) combined with 5-fluorouracil (5-FU) can significantly induce CRC cell apoptosis when compared with the corresponding monotherapies (196). Here, PIK3CA is linked to colorectal carcinoma.